Thiophene-2,5-dicarbonitrile

Catalog No.: 
ACLIPJ478
CAS No.: 
18853-40-2
Molecular Formula: 
C6H2N2S
Molecular Weight: 
134.16
Thiophene-2,5-dicarbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$96.00In stockInquiry
5g97%$334.00In stockIn stock
10g97%$539.00In stockIn stock
25g97%$1073.00InquiryIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameThiophene-2,5-dicarbonitrile
IUPAC Namethiophene-2,5-dicarbonitrile
MDL No.MFCD22987914
Molecular FormulaC6H2N2S
Molecular Weight134.16
SMILESN#CC1=CC=C(C#N)S1
InChI KeyMYINLNBRJVGINA-UHFFFAOYSA-N
SynonymThiophene-2,5-dicarbonitrile;2,5-thiophenedicarbonitrile;2,5-Dicyanothiophene;Thiophene-2,5-dicarbonitrile - [T70927]
CAS No.18853-40-2
PubChem CID140436

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P280-P305+P351+P338-P310

Synthetic Route by SureRoute

1. ACLIPJ478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMYLB158 route compound structure diagram
    ACMYLB1582160-62-5In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACLIPJ478 route product structure diagram
    ACLIPJ47818853-40-2In Stock
Inquiry

2. ACLIPJ478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMYLB158 route compound structure diagram
    ACMYLB1582160-62-5In Stock
  2. Plus
  3. ACFXPJ467 route compound structure diagram
    ACFXPJ46713963-58-1In Stock
  4. Then
  5. ACLIPJ478 route product structure diagram
    ACLIPJ47818853-40-2In Stock
Inquiry

3. ACLIPJ478 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLIPJ478 route product structure diagram
    ACLIPJ47818853-40-2In Stock
Inquiry

Comments (0)